Trailing-twelve-month (TTM) revenue is $1.09 Billion with a year-over-year growth of +17.15%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-28 | $276,892,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $252,338,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-12 |
| Q1 FY2026Period ended 2026-04-05 | $268,437,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-07-05 | $291,263,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-06 |
| TTM revenue | $1,088,930,000 |
Current P/S: $10,807,279,148 market capitalization ÷ $1,088,930,000 TTM revenue = 9.92x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T13:45:14.000Z. Latest revenue period ended 2026-07-05.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-07-05): $291.26M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T13:46:03.657Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Application of Customer Specific Solutions | $136M | $148M | $158M | $103M | $119M | $114M |
| Standard Product and Services | $675M | $889M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas | $310M | $435M | $391M | $330M | $350M | $407M |
| Europe | $209M | $248M | $235M | $221M |
$1.09B
$1.09 Billion
+17.15%
vs. $929.52M a year ago (TTM)
+2.07%
5 Year compound annual growth rate
1 Year
+17.15%
3 Year
+6.83%
5 Year
+2.07%
10 Year
+9.26%
15 Year
+8.56%
20 Year
+7.82%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $994.36M | +$79.84M | +8.73% |
| 2024 | $914.51M | +$76.97M | +9.19% |
| 2023 | $837.55M | ($168.54M) | (16.75%) |
| 2022 | $1.01B | ($31.01M) | (2.99%) |
| 2021 | $1.04B | +$226.08M | +27.88% |
| 2020 |
TTM Growth
+17.15%
3-Year CAGR
+6.83%
5-Year CAGR
+2.07%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T13:46:03.657Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $734M |
| $795M |
| $880M |
| $252M |
| Greater China | $168M | $200M | $227M | $164M | $164M | $158M |
|---|
| Other Asia | $124M | $154M | $153M | $122M | $182M | $177M |
|---|
| $811.02M |
| +$85.39M |
| +11.77% |
| 2019 | $725.63M | ($80.71M) | (10.01%) |
| 2018 | $806.34M | +$40.26M | +5.25% |
| 2017 | $766.08M | +$236.57M | +44.68% |
| 2016 | $529.51M | +$78.96M | +17.52% |
